Skip to main navigation Skip to search Skip to main content

Phase I/II Trial Of Everolimus, Bortezomib and Rituximab In Relapsed Or Relapsed/Refractory Waldenstrom's Macroglobulinemia

  • Irene M. Ghobrial
  • , Erica N Boswell
  • , Stacey Chuma
  • , Ranjit Banwait
  • , Courtney Hanlon
  • , Houry Leblebjian
  • , Diane Warren
  • , Patrick Mostyn
  • , Farzana Masood
  • , Paul G. Richardson
  • , Steven Peter Treon
  • , Jeffrey Matous
  • Harvard University
  • Colorado Blood Cancer Institute, Denver, CO, USA.

Research output: Contribution to journalArticlepeer-review

Original languageAmerican English
JournalBlood
Volume122
Issue number21
DOIs
StatePublished - Nov 15 2013
Externally publishedYes

Disciplines

  • Medicine and Health Sciences
  • Surgery
  • Internal Medicine

Cite this